---
category: news
title: "Opin season arrives for patients as AI drives Opyl boom in Q2 receipts"
excerpt: "Aussie startup Opyl had another strong December quarter â€“ customer registrations have almost doubled as demand for its AI-powered clinical trial recruitment platform, Opin, grows. Medical technology company Opyl (ASX:OPL) has delivered positive Q2 FY22 results with a closing cash balance of $1."
publishedDateTime: 2022-01-30T23:54:00Z
originalUrl: "https://stockhead.com.au/health/opin-season-arrives-for-patients-as-ai-drives-opyl-boom-in-q2-receipts/"
webUrl: "https://stockhead.com.au/health/opin-season-arrives-for-patients-as-ai-drives-opyl-boom-in-q2-receipts/"
ampWebUrl: "https://stockhead.com.au/health/opin-season-arrives-for-patients-as-ai-drives-opyl-boom-in-q2-receipts/?amp"
cdnAmpWebUrl: "https://stockhead-com-au.cdn.ampproject.org/c/s/stockhead.com.au/health/opin-season-arrives-for-patients-as-ai-drives-opyl-boom-in-q2-receipts/?amp"
type: article
quality: 57
heat: 57
published: false

provider:
  name: stockhead
  domain: stockhead.com.au

topics:
  - AI

images:
  - url: "https://stockhead.com.au/wp-content/uploads/2022/01/OPL-scaled.jpg"
    width: 2560
    height: 1725
    isCached: true

secured: "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;5tqal3+tI1jRBvpP6xBitQ=="
---

